1,398 reports of this reaction
3.9% of all INTERFERON BETA 1B reports
#1 most reported adverse reaction
INFLUENZA LIKE ILLNESS is the #1 most commonly reported adverse reaction for INTERFERON BETA 1B, manufactured by Bayer HealthCare Pharmaceuticals Inc.. There are 1,398 FDA adverse event reports linking INTERFERON BETA 1B to INFLUENZA LIKE ILLNESS. This represents approximately 3.9% of all 36,175 adverse event reports for this drug.
Patients taking INTERFERON BETA 1B who experience influenza like illness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INFLUENZA LIKE ILLNESS is moderately reported among INTERFERON BETA 1B users, representing a notable but not dominant share of adverse events.
In addition to influenza like illness, the following adverse reactions have been reported for INTERFERON BETA 1B:
The following drugs have also been linked to influenza like illness in FDA adverse event reports:
INFLUENZA LIKE ILLNESS has been reported as an adverse event in 1,398 FDA reports for INTERFERON BETA 1B. This does not prove causation, but indicates an association observed in post-market surveillance data.
INFLUENZA LIKE ILLNESS accounts for approximately 3.9% of all adverse event reports for INTERFERON BETA 1B, making it one of the most commonly reported side effect.
If you experience influenza like illness while taking INTERFERON BETA 1B, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.